SCHEMBL12212988

SCHEMBL12212988

O=Cc1ccc(C2CCC(C(=O)O)CC2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.62
▸ RAB9A P51151 1/20 0.62
▸ AKR1C3 P42330 1/20 0.51
▸ AKR1C1 Q04828 1/20 0.51
▸ PDE4A P27815 1/20 0.43
▸ PDE4B Q07343 1/20 0.43
▸ PDE4C Q08493 1/20 0.43
▸ PDE4D Q08499 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.42
▸ DGAT1 O75907 3/20 0.42
▸ SOAT1 P35610 1/20 0.42
▸ ESR2 Q92731 3/20 0.38
▸ ALDH5A1 P51649 1/20 0.38
▸ ABAT P80404 1/20 0.38
▸ MAOA P21397 2/20 0.36
▸ MAOB P27338 2/20 0.36
▸ FFAR2 O15552 1/20 0.36
▸ HDAC2 Q92769 1/20 0.36
▸ CYP2A6 P11509 1/20 0.35
▸ USP2 O75604 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12212992 1.00 NPC1 (0.62) NPC1RAB9AAKR1C3AKR1C1PDE4A
SCHEMBL19218160 0.84 CYP2A6 (0.44) ALDH1A1ESR2ALDH5A1ABATMAOA
SCHEMBL741455 0.84 CYP2A6 (0.44) ALDH1A1ESR2ALDH5A1ABATMAOA
SCHEMBL12212993 0.82 ALDH1A1 (0.68) NPC1RAB9AALDH1A1
SCHEMBL12212991 0.82 ALDH1A1 (0.68) NPC1RAB9AALDH1A1
SCHEMBL12212990 0.81 AKR1C3 (0.56) NPC1RAB9AAKR1C3AKR1C1PDE4A
SCHEMBL16574871 0.80 NPC1 (0.51) NPC1RAB9AAKR1C3AKR1C1PDE4A
SCHEMBL16897589 0.80 ALDH1A1 (0.45) NPC1RAB9APDE4APDE4BPDE4C
SCHEMBL8999823 0.79 NPC1 (0.68) NPC1RAB9AAKR1C3AKR1C1ESR2
SCHEMBL8536046 0.79 NPC1 (0.68) NPC1RAB9AAKR1C3AKR1C1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9464166-B2 Production and use of 3,4' and 4,4'-dimethylbiphenyl isomers EXXONMOBIL CHEMICAL PATENTS INC. (US) 2016-10-11 — — US disclosed
US-20150080545-A1 Production and Use of 3,4' and 4,4'-Dimethylbiphenyl Isomers EXXONMOBIL CHEMICAL PATENTS INC. 2015-03-19 — — US disclosed
US-20150080546-A1 Production and Use of 3,4' and 4,4'-Dimethylbiphenyl Isomers EXXONMOBIL CHEMICAL PATENTS INC. 2015-03-19 — — US disclosed
US-20110250509-A1 SECONDARY BATTERY AND ELECTRONIC DEVICE SONY CORPORATION (JP) 2011-10-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150080546-A1 Production and Use of 3,4' and 4,4'-Dimethylbiphenyl Isomers CYP4B1, HPD, DDT NPC1 4871/4885RAB9A 4370/4885AKR1C3 187/4885
US-20150080545-A1 Production and Use of 3,4' and 4,4'-Dimethylbiphenyl Isomers CYP4B1, HPD, DDT NPC1 4871/4885RAB9A 4370/4885AKR1C3 187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback